Zobrazeno 1 - 10
of 432
pro vyhledávání: '"KAZUHIRO YATERA"'
Autor:
Tomotsugu Takano, Kazuya Tsubouchi, Naoki Hamada, Katsuyuki Ichiki, Ryo Torii, Shohei Takata, Satoru Kawakami, Noriaki Nakagaki, Makoto Yoshida, Yasuhiko Kitasato, Kazunori Tobino, Eiji Harada, Hiroshi Ishii, Hiroshi Wataya, Takashige Maeyama, Masaki Fujita, Kazuhiro Yatera, Masaki Okamoto, Hidetake Yabuuchi, Fumiaki Kiyomi, Shoji Tokunaga, Yoichi Nakanishi, Isamu Okamoto
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background We conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s. Methods This prospective cohort stu
Externí odkaz:
https://doaj.org/article/c2759ff9a1084daa8d96ae84202cdfaa
Autor:
Taisuke Tomonaga, Hidenori Higashi, Hiroto Izumi, Chinatsu Nishida, Naoki Kawai, Kazuma Sato, Toshiki Morimoto, Yasuyuki Higashi, Kazuhiro Yatera, Yasuo Morimoto
Publikováno v:
Particle and Fibre Toxicology, Vol 21, Iss 1, Pp 1-16 (2024)
Abstract Background Microplastics have been detected in the atmosphere as well as in the ocean, and there is concern about their biological effects in the lungs. We conducted a short-term inhalation exposure and intratracheal instillation using rats
Externí odkaz:
https://doaj.org/article/7f7aeab85fcb401faaf88141f747aab2
Autor:
Shingo Noguchi, Masahiro Katsurada, Kazuhiro Yatera, Natsuki Nakagawa, Dongjie Xu, Yosuke Fukuda, Yuichiro Shindo, Kazuyoshi Senda, Hiroki Tsukada, Makoto Miki, Hiroshi Mukae
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Accurate prognostic tools for mortality in patients with healthcare-associated pneumonia (HCAP) are needed to provide appropriate medical care, but the efficacy for mortality prediction of tools like PSI, A-DROP, I-ROAD, and CURB-65, widely
Externí odkaz:
https://doaj.org/article/76b5a78296c64c7c8ddb462781a85791
Autor:
Yosuke Chiba, Tomomitsu Doi, Kunie Obayashi, Kazuhiro Sumida, Shohei Nagasaka, Ke-Yong Wang, Kei Yamasaki, Katsuhiro Masago, Hirokazu Matsushita, Hiroaki Kuroda, Kazuhiro Yatera, Motoyoshi Endo
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-14 (2024)
Abstract Caspase-4 (CASP4) is a member of the inflammatory caspase subfamily and promotes inflammation. Here, we report that CASP4 in lung adenocarcinoma cells contributes to both tumor progression via angiogenesis and tumor hyperkinesis and tumor ce
Externí odkaz:
https://doaj.org/article/ff46145806814e5e9d3f9110483eb902
Publikováno v:
Respirology Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Abstract Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory disease induced by exaggerated immune responses to Aspergillus species. Although ABPA has a high recurrence (48%), its instances with sequential isolation of distinct Aspergil
Externí odkaz:
https://doaj.org/article/392e7d6356144c3399afc060d02a74b5
Autor:
Kentaro Akata, Kei Yamasaki, Yosuke Chiba, Takako Kawaguchi, Hiroki Dosaka, Toshiki Morimoto, Yasuyuki Higashi, Chinatsu Nishida, Shohei Shimajiri, Kazuhiro Yatera
Publikováno v:
Thoracic Cancer, Vol 15, Iss 5, Pp 410-414 (2024)
Abstract A 20‐year‐old Japanese man visited our hospital because an enlarged mediastinal shadow had been detected on chest x‐ray. Chest computed tomography revealed a large mediastinal mass with multiple lymph node enlargement, pericardial effu
Externí odkaz:
https://doaj.org/article/788b66ca69604b31803fd4acf2f77889
Autor:
Takako Kawaguchi, Kei Yamasaki, Saki Shigemi, Hiroki Dosaka, Riho Hirosawa, Taiga Nagasawa, Satoshi Fujimoto, Shohei Shimajiri, Kazuhiro Yatera
Publikováno v:
Respirology Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract A 69‐year‐old ex‐smoker Japanese man presented with a left mediastinal lymph node and left upper lobe tumour. Bronchoscopic biopsy specimens from the enlarged left mediastinal lymph node and left upper lobe tumour revealed small cell l
Externí odkaz:
https://doaj.org/article/42273598eccc48088a5b00eb6dd44573
Autor:
Masaki Okamoto, Kiminori Fujimoto, Takeshi Johkoh, Atsushi Kawaguchi, Hiroshi Mukae, Noriho Sakamoto, Takashi Ogura, Satoshi Ikeda, Yasuhiro Kondoh, Yasuhiko Yamano, Kosaku Komiya, Kenji Umeki, Hirotaka Nishikiori, Yoshinori Tanino, Toru Tsuda, Naoki Arai, Masamichi Komatsu, Susumu Sakamoto, Kazuhiro Yatera, Yoshikazu Inoue, Yasunari Miyazaki, Seishu Hashimoto, Yasuo Shimizu, Hironao Hozumi, Hiroshi Ohnishi, Tomohiro Handa, Noboru Hattori, Tomoo Kishaba, Motoyasu Kato, Minoru Inomata, Hiroshi Ishii, Naoki Hamada, Satoshi Konno, Yoshiaki Zaizen, Arata Azuma, Takafumi Suda, Kenji Izuhara, Tomoaki Hoshino
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract This study investigated the utility of periostin, a matricellular protein, as a prognostic biomarker in patients with idiopathic pulmonary fibrosis (IPF) who received nintedanib. Monomeric and total periostin levels were measured by enzyme-l
Externí odkaz:
https://doaj.org/article/2b2e68e74c41415c98d7b25f9fb2eba1
Autor:
Taiga Miyazaki, Kiyoyasu Fukushima, Kohji Hashiguchi, Shotaro Ide, Tsutomu Kobayashi, Toyomitsu Sawai, Kazuhiro Yatera, Yoshihisa Kohno, Yuichi Fukuda, Yoji Futsuki, Yuichi Matsubara, Hironobu Koga, Tomo Mihara, Eisuke Sasaki, Nobuyuki Ashizawa, Tatsuro Hirayama, Takahiro Takazono, Kazuko Yamamoto, Yoshifumi Imamura, Norihito Kaku, Kosuke Kosai, Yoshitomo Morinaga, Katsunori Yanagihara, Hiroshi Mukae
Publikováno v:
Pneumonia, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background Current microbiological tests fail to identify the causative microorganism in more than half of all pneumonia cases. We explored biomarkers that could be used for differentiating between bacterial and viral pneumonia in patients w
Externí odkaz:
https://doaj.org/article/2ad387cfd3fd4f8cb035a4a44643fca2
Autor:
Toshiki Morimoto, Kei Yamasaki, Tatsuya Shingu, Yasuyuki Higashi, Yukinori Maeda, Takumu Uryu, Naoto Kubo, Takako Kawaguchi, Chinatsu Nishida, Kazuhiro Yatera
Publikováno v:
Thoracic Cancer, Vol 14, Iss 29, Pp 2981-2984 (2023)
Abstract Epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI)‐targeted therapy has emerged as a viable treatment for patients with advanced non‐small cell lung cancer with common EGFR mutations. The uncommon G719X and S768I m
Externí odkaz:
https://doaj.org/article/80bb69cf70464f549767fa05341bce2f